Modi Karuna P, Lahiri Suman K, Goswami Sunita S, Santani Dev D, Shah Mamta B
L. M. College of Pharmacy, Ahmedabad.
J Complement Integr Med. 2012 Aug 10;9:Article 18. doi: 10.1515/1553-3840.1630.
The study was aimed to investigate antiulcer effects of acetone extract and its different fractions Mimusops hexandra against experimental gastro-duodenal ulcers. 80% acetone extract of stem bark of Mimusops hexandra (Extract A, p.o.) and its different fractions namely diethyl ether (Extract A1, p.o.), ethyl acetate (Extract A2, p.o.) and aqueous (Extract A3, p.o.) were tested for the presence of preliminary phytoconstituents and were screened for their antiulcer potential in experimental animals using ethanol-HCl and aspirin-induced gastric damage at the dose of 500 mg kg-1p.o. Extract A2 being the most active fraction amongst all the fractions tested was also studied at different doses to find its ED50. Further, to establish the mechanism of action, Extract A2 was also tested for its effects in acetic acid-induced gastric ulcer models and cysteamine-induced duodenal ulcer. The effect was compared with cimetidine. Flavonoids (quercetin), procyanidins, saponins and triterpenoids were found to be present in bark. Oral administration of Extract A2 inhibited formation of gastric lesions induced by aspirin in a dose dependent manner. Elevated level of lipid peroxidation due to ethanol-HCl and aspirin induced gastric damage was significantly (p<0.05) reduced by the treatment with Extract A2. Further, Extract A2 at the dose of 100 mg kg-1 (p.o.) reduced extent of acetic acid induced gastric ulcer in experimental animals. Moreover, protection afforded by Extract A2 against cysteamine-induced duodenal lesions was evident from dose dependent decrease in ulcer index (p<0.05), score for intensity (p<0.05) and total lesion area (p<0.05), when compared with the control group. The antiulcer activity shown by Extract A2 in experimental gastro-duodenal ulcer could be attributed to decrease in gastric acid secretory activity along with strengthening of mucosal defensive mechanisms.
本研究旨在探讨六蕊铁线子丙酮提取物及其不同馏分对实验性胃十二指肠溃疡的抗溃疡作用。对六蕊铁线子茎皮的80%丙酮提取物(提取物A,口服)及其不同馏分,即乙醚提取物(提取物A1,口服)、乙酸乙酯提取物(提取物A2,口服)和水提取物(提取物A3,口服)进行了初步植物成分分析,并以500 mg kg-1口服剂量,在实验动物中利用乙醇 - 盐酸和阿司匹林诱导的胃损伤,对其抗溃疡潜力进行了筛选。提取物A2是所有测试馏分中活性最高的馏分,还对其不同剂量进行了研究以确定其半数有效剂量(ED50)。此外,为了确定作用机制,还在乙酸诱导的胃溃疡模型和半胱胺诱导的十二指肠溃疡模型中测试了提取物A2的作用。将结果与西咪替丁进行了比较。发现树皮中存在黄酮类化合物(槲皮素)、原花青素、皂苷和三萜类化合物。口服提取物A2以剂量依赖性方式抑制了阿司匹林诱导的胃损伤形成。用提取物A2治疗可显著(p<0.05)降低乙醇 - 盐酸和阿司匹林诱导的胃损伤导致的脂质过氧化水平升高。此外,提取物A2以100 mg kg-1(口服)的剂量降低了实验动物中乙酸诱导的胃溃疡程度。此外,与对照组相比,提取物A2对半胱胺诱导的十二指肠损伤的保护作用从溃疡指数(p<0.05)、强度评分(p<0.05)和总损伤面积(p<0.05)的剂量依赖性降低中明显可见。提取物A2在实验性胃十二指肠溃疡中显示的抗溃疡活性可能归因于胃酸分泌活性的降低以及黏膜防御机制的增强。